Japanese scientists develop a new device for metronomic photodynamic therapy to facilitate a minimally-invasive and effective cancer treatment in delicate organs
Scientists from Waseda University, the National Defense Medical College, and the Japan Science and Technology Agency developed a new bioadhesive, wirelessly-powered light-emitting device which could better treat cancers in delicate organs.
Conventional photodynamic therapy induces cancer cell death by using photosensitizing agents, which localize in tumors and activate with exposure to a specific wavelength of light. In recent years, low-dose and long-term photodynamic therapy (metronomic photodynamic therapy, mPDT) has shown promise in treating cancers in internal organs. The problem with mPDT is, however, is that because the light intensity is extremely low (1/1000 of the conventional method), the antitumor effect cannot be obtained if the light source shifts even slightly away from the tumor, making the illumination insufficient.
“To address this issue, we have developed a wirelessly-powered optoelectronic device that stably fixes itself onto the inner surface of an animal tissue like a sticker with bioadhesive and elastic nanosheets, enabling a continuous, local light delivery to the tumor,” says Toshinori Fujie, associate professor of biomedical engineering at Waseda University. The nanosheets are modified with the mussel adhesive protein-inspired polymer polydopamine, which can stabilize the device onto a wet animal tissue for more than 2 weeks without surgical suturing or medical glue. The light-emitting diode chips in the device are wirelessly powered by near-field-communication technology.
To test its effectiveness, tumor-bearing mice implanted with the device were injected with a photosensitizing agent (photofrin) and exposed to red and green light, approximately 1,000-fold intensity lower than the conventional PDT approaches, for 10 consecutive days. The experiment showed that the tumor growth was significantly reduced overall. Especially under green light, the tumor in some mice was completely eradicated.
Associate Professor Fujie points out, “This device may facilitate treatment for hard-to-detect microtumors and deeply located lesions that are hard to reach with standard phototherapy, without having to worry about the risk of damaging healthy tissues by overheating. Furthermore, because the device does not require surgical suturing, it is suitable for treating cancer near major nerves and blood vessels, as well as for organs that are fragile, that change their shape, or that actively move, such as the brain, liver, and pancreas.”
If clinically applied, the device could be beneficial for cancer patients who seek minimally invasive treatment, helping them live longer and improve their quality of life.
The Latest on: Photodynamic therapy
via Google News
The Latest on: Photodynamic therapy
- Sun Pharma arm gets relief from US court in patent infringement case on December 26, 2018 at 5:58 pm
The lawsuit alleged trade secret misappropriation and patent infringement of DUSA's photodynamic therapy patents covering its product.PTI | December 27, 2018, 07:28 IST NEW DELHI: Sun Pharma ... […]
- Photodynamic Therapy (PDT) Market Is Expected To Grow At An Impressive Growth With A 5.7% CAGR – Credence Research on December 26, 2018 at 3:58 am
The latest market report published by Credence Research, Inc. “Global Photodynamic Therapy (PDT) Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global photodynamic therapy ... […]
- OCTA Imaging of Choroidal Neovascularization Treated Using Photodynamic Therapy in a Young Patient With Best Macular Dystrophy on December 20, 2018 at 1:19 pm
This study reports the onset of a choroidal neovascularization (CNV) in a young patient affected with Best macular dystrophy (BMD) using optical coherence tomography angiography (OCTA) and describes i... […]
- Morphological and Functional Changes Immediately After Half-Time Photodynamic Therapy in Patients With Central Serous Chorioretinopathy on December 20, 2018 at 1:09 pm
The anatomical and functional results were assessed for 24 eyes of 23 patients with CSC treated with half-time PDT in this prospective case series. Central foveal thickness (CFT) and subfoveal choroid... […]
- The global dermatologists market was valued at $37.2 billion in 2017 on December 10, 2018 at 3:26 pm
And the USA was the largest country accounting for $14.9 billion or 0.4% of the global dermatologists market. Daylight photodynamic therapy (PDT) is one of the major trends in this market. Developed a ... […]
- Less Drug, Stronger Laser Beam Allow Photodynamic Therapy To Reach Deep Chest Cancer Lesions, UB Researchers Find on November 29, 2018 at 4:00 pm
RENO, NEV. -- Photodynamic therapy (PDT), one of the most promising new cancer treatments, may have much wider application than previously thought, new research by University at Buffalo researchers ha... […]
- BMP’s Gang Han, PhD, discusses Photodynamic Therapy – A Non-Toxic Way to Fight Cancer. on November 14, 2018 at 4:00 pm
Using photodynamic therapy, an up and coming treatment model for certain cancers, doctors can treat certain types of cancers with non-toxic light-emitting molecules, photosensitizers, and light. Resea... […]
- Thomas Dougherty, Ph. D., developed modern cancer therapy on October 5, 2018 at 4:58 pm
Dr. Dougherty, the developer of modern photodynamic therapy (PDT) and chief emeritus of Roswell Park’s Photodynamic Therapy Center, died Tuesday, Oct. 2, in Highland Hospital in Rochester after a shor... […]
- Photodynamic Therapy of Vulvar Lichen Sclerosus With 5-Aminolevulinic Acid on May 7, 2018 at 7:37 am
Objective To evaluate the therapeutic effect of photodynamic therapy on vulvar lichen sclerosus. Results Two women underwent two cycles of photodynamic therapy, one underwent three cycles, and the rem... […]
via Bing News